New scientific studies on GLP-1 group drugs, which are used in the treatment of diabetes and have become widespread in recent years for weight control, indicate that the effects of these drugs may not be limited to the metabolic system only. Research is being carried out that drugs with active ingredients, especially Ozempic and similar ones, may cause changes in some neural networks in the brain. These studies evaluate that cognitive and behavioral processes beyond appetite regulation may also be affected.
Changes Observed in Brain Networks In some recent studies, differences in certain network connections were detected in the brain imaging of individuals using GLP-1 drugs. Changes were reported especially in the regions called “salience network”, which play a role in directing attention and selecting important stimuli. Researchers state that it is not yet clear how these changes occur. Whether the findings are a direct effect on brain receptors or an indirect result of metabolic improvements continues to be investigated.
Different Views on the Mechanism of Action There are two basic approaches in the scientific world regarding the effects of GLP-1 drugs on the brain. The first view suggests that these drugs may cross the blood-brain barrier and act directly on the central nervous system. The other approach is that indirect physiological changes, such as weight loss, blood sugar regulation and decreases in inflammation levels, may affect brain functions.
Researchers also consider that both mechanisms may play a role together. Studies on the Reward System and Behavioral Effects Another area that GLP-1 drugs are thought to affect is the reward mechanism of the brain. This system is involved in processes related to motivation and pleasure, especially eating behavior. While some research suggests that these drugs may have suppressive effects on addictive behaviors, it is also being scientifically examined whether there are changes in daily motivation and enjoyment processes.
Experts stated that the effects of GLP-1 drugs on the brain are based on early stage studies and more data is needed to clarify long-term results.
Comments
You can write your views about this story. Comments may be moderated according to site settings.